Rocket Pharmaceuticals (RCKT) Other Non Operating Income (2015)

Rocket Pharmaceuticals' (RCKT) quarterly Other Non Operating Income came in at -$46.6 million in Q3 2015, down 2609.36% quarter-over-quarter from $1.9 million in Q2 2015.

Rocket Pharmaceuticals (RCKT) Other Non Operating Income (2015) Analysis & Trends

Rocket Pharmaceuticals has disclosed Other Non Operating Income across 1 years of filings, most recently posting -$46.6 million for Q3 2015.

  • Other Non Operating Income for Q3 2015 came in at -$46.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was -$42.8 million (changed N/A YoY), and the FY2015 annual result was -$42.8 million, changed N/A from the prior year.
  • Other Non Operating Income came in at -$46.6 million for Q3 2015 at Rocket Pharmaceuticals, down from $1.9 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.0 million in Q1 2015 to a low of -$46.6 million in Q3 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 Rocket Pharmaceuticals 296.03 Mn 296.03 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2015 -46.65 Mn
Jun 30, 2015 1.86 Mn
Mar 31, 2015 2.00 Mn